THE OBJECTIVE OF THIS PHASE I PROPOSAL IS TO CONDUCT PILOT STUDIES TOWARD DEVELOPMENT OF A RAPID, RELIABLE AND SENSITIVE IN VIVO ASSAY FOR SCREENING POTENTIAL HEPATOCARCINOGENS.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1984
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
1423
Agency Tracking Number:
1423
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
763d Concord Ave, Cambridge, MA, 02138
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ELLEN ESSIGMANN
SENIOR TOXICOLOGIST
() -
Business Contact:
() -
Research Institute:
n/a
Abstract
THE OBJECTIVE OF THIS PHASE I PROPOSAL IS TO CONDUCT PILOT STUDIES TOWARD DEVELOPMENT OF A RAPID, RELIABLE AND SENSITIVE IN VIVO ASSAY FOR SCREENING POTENTIAL HEPATOCARCINOGENS. THE RESEARCH EFFORT IS DESIGNED TO PROVIDE PRELIMINARY INFORMATION ON THE FEASIBILITY OF USING THE CHOLINE DEFICIENT RAT, A MODEL FOR LIVER TUMOR PROMOTION, FOR THIS PURPOSE. TO ACCOMPLISH THIS GOAL, MALE WEANLING RATS WILL BE MAINTAINED ON HIGH FAT SEMI-SYNTHETIC DIETS THAT VARY IN CHOLINE CONTENT. RATS WILL THEN BE SUBJECTED TO EITHER ACUTE OR SUBACUTE INTRAGASTRIC DOSING REGIMENS WITH VEHICLE, A POTENT NEPATOCARCINOGEN (AFB1) OR PHENOBARBITAL, A NONCARCINOGENIC STIMULATOR OF HEPATOCELLULAR HYPERTROPHY AND HYPERPLASIA. SELECTED HISTOPATHOLOLOGIC, HISTOCHEMICAL, IMMUNOCYTOCHEMICAL AND BLOOD SERUM PARAMETERS POTENTIALLY USEFUL IN DETECTING OR PREDICTING NEOPLASTIC CHANGE WILL BE EVALUATED OVER TIME. RESULTS WILL BE ANALYZED FOR EVIDENCE OF DIETARY AND DOSING REGIMEN EFFECTS ON TYPE, INCIDENCE, RATE OF DEVELOPMENT AND PERSISTENCE OF LIVER LESIONS. DATA INTERPRETATION WILL ALLOW DETERMINATION OF WHETHER THE CHOLINE DEFICIENT RAT MODEL SHOWS PROMISE AS A RAPID CARCINOGEN BIOASSAY SYSTEM. PHASE II RESEARCH WILL BE DIRECTED TOWARD DETERMINATION OF THE SENSITIVITY AND SPECIFICITY OF THE ASSAY AND TOWARD FURTHER DEVELOPMENT FOR COMMERCIAL EXPLOITATION. SUCCESSFUL COMPLETION OF THIS PROJECT WILL ALLOW DEVELOPMENT OF A COMMERCIALLY IMPORTANT BIOASSAY SYSTEM FOR USE IN CONTRACT TOXICOLOGY COMPANIES AND IN INDUSTRIES THAT PRODUCE COMPOUNDS REQUIRING ASSESSMENT FOR CARCINOGENICITY. THIS RESEARCH AREA IS OF INTEREST TO NCI, NIEHS AND FDA.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government